APOE and Alzheimer disease: Although this observation can be explained in part by population differences in the ε4 frequency, the ethnic difference in the ε4/ε4-mediated increased risk for AD and neurodegeneration is likely a direct consequence moderating effects on APOE expression by rs405509 genotypes, whose frequencies vary widely across EastAs, EuroAs, and AAs.